ArticleInflammatory intestinal diseases

Optimal Use of Serum Leucine-Rich Alpha-2 Glycoprotein as a Biomarker for Small Bowel Lesions of Crohn's Disease.

Kunio Asonuma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.